LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Dovitinib | 0.04 | uM | LJP5 | 3 | E24 | 72 | hr | 1476 | 2575 | 3694 | 0.6971 | 0.4953 |
SK-BR-3 | Enzastaurin | 0.04 | uM | LJP5 | 1 | D18 | 72 | hr | 1476 | 4152 | 3694 | 1.1240 | 1.2065 |
SK-BR-3 | Enzastaurin | 0.04 | uM | LJP5 | 2 | D18 | 72 | hr | 1476 | 4409 | 3694 | 1.1935 | 1.3224 |
SK-BR-3 | Enzastaurin | 0.04 | uM | LJP5 | 3 | D18 | 72 | hr | 1476 | 4321 | 3694 | 1.1697 | 1.2827 |
SK-BR-3 | Erlotinib | 0.04 | uM | LJP5 | 1 | M24 | 72 | hr | 1476 | 3297 | 3694 | 0.8925 | 0.8209 |
SK-BR-3 | Erlotinib | 0.04 | uM | LJP5 | 2 | M24 | 72 | hr | 1476 | 2957 | 3694 | 0.8005 | 0.6676 |
SK-BR-3 | Erlotinib | 0.04 | uM | LJP5 | 3 | M24 | 72 | hr | 1476 | 2840 | 3694 | 0.7688 | 0.6148 |
SK-BR-3 | Foretinib | 0.04 | uM | LJP5 | 1 | H12 | 72 | hr | 1476 | 3965 | 3694 | 1.0733 | 1.1222 |
SK-BR-3 | Foretinib | 0.04 | uM | LJP5 | 2 | H12 | 72 | hr | 1476 | 3988 | 3694 | 1.0796 | 1.1326 |
SK-BR-3 | Foretinib | 0.04 | uM | LJP5 | 3 | H12 | 72 | hr | 1476 | 3912 | 3694 | 1.0590 | 1.0983 |
SK-BR-3 | R406 | 0.04 | uM | LJP6 | 1 | C18 | 72 | hr | 1476 | 3791 | 3694 | 1.0262 | 1.0437 |
SK-BR-3 | R406 | 0.04 | uM | LJP6 | 2 | C18 | 72 | hr | 1476 | 3673 | 3694 | 0.9943 | 0.9905 |
SK-BR-3 | R406 | 0.04 | uM | LJP6 | 3 | C18 | 72 | hr | 1476 | 4050 | 3694 | 1.0964 | 1.1605 |
SK-BR-3 | Pictilisib | 0.04 | uM | LJP6 | 1 | D24 | 72 | hr | 1476 | 2074 | 3694 | 0.5614 | 0.2694 |
SK-BR-3 | Pictilisib | 0.04 | uM | LJP6 | 2 | D24 | 72 | hr | 1476 | 2162 | 3694 | 0.5853 | 0.3091 |
SK-BR-3 | Pictilisib | 0.04 | uM | LJP6 | 3 | D24 | 72 | hr | 1476 | 2337 | 3694 | 0.6326 | 0.3880 |
SK-BR-3 | Gefitinib | 0.04 | uM | LJP6 | 1 | N12 | 72 | hr | 1476 | 3244 | 3694 | 0.8782 | 0.7970 |
SK-BR-3 | Gefitinib | 0.04 | uM | LJP6 | 2 | N12 | 72 | hr | 1476 | 3536 | 3694 | 0.9572 | 0.9287 |
SK-BR-3 | Gefitinib | 0.04 | uM | LJP6 | 3 | N12 | 72 | hr | 1476 | 3520 | 3694 | 0.9529 | 0.9215 |
SK-BR-3 | Geldanamycin | 0.04 | uM | LJP5 | 1 | O06 | 72 | hr | 1476 | 1446 | 3694 | 0.3914 | -0.0139 |
SK-BR-3 | Geldanamycin | 0.04 | uM | LJP5 | 2 | O06 | 72 | hr | 1476 | 1403 | 3694 | 0.3798 | -0.0332 |
SK-BR-3 | Geldanamycin | 0.04 | uM | LJP5 | 3 | O06 | 72 | hr | 1476 | 1567 | 3694 | 0.4242 | 0.0407 |
SK-BR-3 | Geldanamycin | 0.04 | uM | LJP6 | 1 | O06 | 72 | hr | 1476 | 1487 | 3694 | 0.4025 | 0.0046 |
SK-BR-3 | Geldanamycin | 0.04 | uM | LJP6 | 2 | O06 | 72 | hr | 1476 | 1543 | 3694 | 0.4177 | 0.0299 |
SK-BR-3 | Geldanamycin | 0.04 | uM | LJP6 | 3 | O06 | 72 | hr | 1476 | 1448 | 3694 | 0.3920 | -0.0130 |